| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/01/2012 | EP1932833B1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 08/01/2012 | EP1871749B1 Selurampanel |
| 08/01/2012 | EP1869011B1 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors |
| 08/01/2012 | EP1819697B1 3-(indolyl)-4-arylmaleimide derivatives and their use as angiogenesis inhibitors |
| 08/01/2012 | EP1753421B1 Arylsulfonamides and uses as hydroxysteroid dehydrogenase |
| 08/01/2012 | CN1918137B Tetrazole compounds and their use as metabotropic glutamate receptor antagonists |
| 08/01/2012 | CN102625806A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 08/01/2012 | CN102625804A Compounds useful for treating AIDS |
| 08/01/2012 | CN102617554A Two-photon fluorescent probe taking naphthaline as matrix as well as preparation method and application thereof |
| 08/01/2012 | CN102617464A fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 07/31/2012 | US8232395 Method for producing 2-(2-aminopyrimidin-4-yl)-1H-indole-5-carboxylic acid derivatives |
| 07/31/2012 | US8232376 Azo compound and method of preparing the azo compound |
| 07/31/2012 | US8232312 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions |
| 07/31/2012 | US8232297 Sulphonylpyrroles as inhibitors of HDACs novel sulphonylpyrroles |
| 07/31/2012 | US8232285 Quinazolinone compounds and methods of use thereof |
| 07/31/2012 | US8232274 Pyridazinone derivatives useful as glucan synthase inhibitors |
| 07/31/2012 | US8232269 Amide compounds useful in therapy |
| 07/31/2012 | US8231984 Quinoxaline derivative, and organic semiconductor device, electric field light emitting device, and electronic device which have the same |
| 07/31/2012 | CA2666310C Substituted imidazoles as bombesin receptor subtype-3 modulators |
| 07/31/2012 | CA2565708C 5,6-diphenyl-1,2,4-triazinic dimeric derivatives and the use thereof in the form of sun-protective agents |
| 07/31/2012 | CA2539909C 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 07/26/2012 | WO2012099736A2 Improved process for preparation of high molecular weight molybdenum succinimide complexes |
| 07/26/2012 | WO2012099734A2 Improved process for preparation of low molecular weight molybdenum succinimide complexes |
| 07/26/2012 | WO2012099219A1 Organic electroluminescent element |
| 07/26/2012 | WO2012098132A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer |
| 07/26/2012 | WO2012098033A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases |
| 07/26/2012 | WO2012051553A3 Nanofiber-based heterojunction approach for high photoconductivity on organic materials |
| 07/26/2012 | US20120190854 Hydroamination of Alkenes |
| 07/26/2012 | US20120190853 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses |
| 07/26/2012 | US20120190846 Michael addition reaction product and active energy ray-curable composition |
| 07/26/2012 | US20120190845 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor |
| 07/26/2012 | US20120190700 Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer |
| 07/26/2012 | US20120190693 Reverse Amide Compounds As Protein Deacetylase Inhibitors And Methods Of Use Thereof |
| 07/26/2012 | US20120190689 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist |
| 07/26/2012 | US20120190687 Pyrazinylpyrazoles |
| 07/26/2012 | US20120190686 Bicyclo[3.2.1]octyl amide derivatives and uses of same |
| 07/26/2012 | US20120190684 Insecticidal substituted azinyl derivatives |
| 07/26/2012 | US20120190682 Modulators for amyloid beta |
| 07/26/2012 | US20120190680 Heteroaryl Amide Analogues |
| 07/26/2012 | US20120190673 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/26/2012 | US20120190649 Bicyclic aryl sphingosine 1-phosphate analogs |
| 07/26/2012 | US20120190543 Pesticidal compositions |
| 07/26/2012 | US20120189623 Cyclized derivatives as eg-5 inhibitors |
| 07/26/2012 | US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same |
| 07/26/2012 | US20120187391 Aromatic amine derivative, organic device material and hole-injection/transport material and organic electroluminescent element material each comprising the derivative, and organic electroluminescent element |
| 07/26/2012 | CA2824460A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases |
| 07/26/2012 | CA2824349A1 Improved process for preparation of low molecular weight molybdenum succinimide complexes |
| 07/26/2012 | CA2823780A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer |
| 07/26/2012 | CA2818196A1 Improved process for preparation of high molecular weight molybdenum succinimide complexes |
| 07/25/2012 | EP2479175A1 Compounds and methods for treating dyslipidemia |
| 07/25/2012 | EP2479174A1 6-amino quinazoline or 3-cyano quinoline derivatives, preparation methods and pharmaceutical uses thereof |
| 07/25/2012 | EP2479168A1 6-Substituted 2,3,4,5-Tetrahydro-1H-Benzo [d]Azepines as 5-HT2C Receptor Agonists |
| 07/25/2012 | EP2477981A1 Heterocyclic mglu5 antagonists |
| 07/25/2012 | EP2477980A1 Hcv protease inhibitors |
| 07/25/2012 | EP2477979A1 Compounds for organic light emitting diode emissive layers |
| 07/25/2012 | EP2477978A1 Salts of sunitinib |
| 07/25/2012 | EP2477977A2 Treatment for oxidative stress and/or hypertension |
| 07/25/2012 | EP2477976A1 Quinazolinone derivatives as viral polymerase inhibitors |
| 07/25/2012 | EP2280961B1 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands |
| 07/25/2012 | EP2205558B1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
| 07/25/2012 | EP1891063B1 Bicyclic derivatives as modulators of ion channels |
| 07/25/2012 | EP1891019B1 2,6-substituted-4-monosubstitutedamino-pyrimidines as prostaglandin d2 receptor antagonists |
| 07/25/2012 | EP1723121B1 1,4-diaryl-dihydropyrimidin-2-ones and their use as human neutrophil elastase inhibitors |
| 07/25/2012 | EP1257544B1 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 07/25/2012 | EP1252162B1 Alpha v integrin receptor antagonists |
| 07/25/2012 | CN102612516A Substituted pyrrolidine-2-carboxamides |
| 07/25/2012 | CN102603718A Synthesis method of cediranib |
| 07/25/2012 | CN102603717A Pyrrylketone compound and application thereof as drug |
| 07/25/2012 | CN102603713A Chiral CB1 (cannabinoid) receptor inhibitor, and preparation method and medical application thereof |
| 07/25/2012 | CN102603660A Preparation method of 1H-1,2,3-triazole compound |
| 07/25/2012 | CN102603619A Compound with anticancer activity and preparation method thereof |
| 07/25/2012 | CN102603610A 1,3-dihydro-1-oxo-2H-isobenzazole compounds as well as preparation method and use thereof |
| 07/25/2012 | CN101838245B Quinazoline derivant or pharmaceutical salt thereof, preparation method and application thereof |
| 07/24/2012 | US8227614 Methods of nanoassembly of a fractal polymer and materials formed thereby |
| 07/24/2012 | US8227605 2-aminothiazole-4-carboxylic amides as protein kinase inhibitors |
| 07/24/2012 | US8227604 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering CNS activity |
| 07/24/2012 | US8227594 Antiviral nucleosides |
| 07/24/2012 | US8227504 Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof |
| 07/24/2012 | US8227485 Benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 07/24/2012 | US8227478 JNK modulators |
| 07/24/2012 | US8227472 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors |
| 07/24/2012 | US8227469 Vanilloid receptor ligands and their use in treatments |
| 07/24/2012 | CA2687180C Novel amide derivative for inhibiting the growth of cancer cells |
| 07/24/2012 | CA2517427C Antiprotozoal imidazopyridine compounds |
| 07/24/2012 | CA2476065C Inhibitors of histone deacetylase |
| 07/19/2012 | WO2012097177A2 Substituted benzoazepines as toll-like receptor modulators |
| 07/19/2012 | WO2012097173A2 Substituted benzoazepines as toll-like receptor modulators |
| 07/19/2012 | WO2012096929A2 Heteroaryl compounds and methods of use thereof |
| 07/19/2012 | WO2011141909A3 Lipoic acid and nitroxide derivatives and uses thereof |
| 07/19/2012 | US20120184583 Modulators of atp-binding cassette transporters |
| 07/19/2012 | US20120184582 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same |
| 07/19/2012 | US20120184580 Substituted di-arylhydantoin and di-arylthiohydantoin compounds and methods of use thereof |
| 07/19/2012 | US20120184561 Phenylacetamides suitable as protein kinase inhibitors |
| 07/19/2012 | US20120184556 Substituted enzoimidazolesulfonamides and substituted indolesulfonamides as mglur4 potentiators |
| 07/19/2012 | US20120184535 Compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |
| 07/19/2012 | US20120184533 Small molecule inhibitors of parp activity |
| 07/19/2012 | US20120184530 Dimeric IAP Inhibitors |
| 07/19/2012 | US20120184523 C-Met Modulators and Method of Use |
| 07/19/2012 | US20120184520 Glycine compound |
| 07/19/2012 | US20120184518 Methods of treating or preventing an inflammatory disease or condition using glutaminyl cyclase inhibitors |